October 2, 2023
- May 26, 2023 - Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities. See Notice NOT-HL-23-083.
- May 10, 2022 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional). See NOFO PAR-22-105.
- October 12, 2021 - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional). See NOFO PAR-21-341.
- November 12, 2020 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required). See NOFO PAR-21-035.
- May 5, 2020 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed). See NOFO PA-20-185.
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding NOT-HL-23-083 “Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities”.
The FAQs are available on the NHLBI website at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/NOT-HL-23-091.
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
Scientific and Research Contacts
Fernando P. Bruno, MD, MPH
Center for Translation Research & Implementation Science (CTRIS)
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-0886
Email: [email protected]
Robin C. Vanderpool, DrPH
Health Communication and Informatics Research Branch
National Cancer Institute (NCI)
Telephone: 240-276-6558
Email: [email protected]
and Human Services (HHS)
